921
The federal government has put a cap on distribution of monoclonal antibody treatments to Florida, giving the state 36,000 doses, which is not enough to meet the demands of the state’s 25 treatment sites.
Tampa General CEO John Couris testified Monday before the Florida Legislature about what that means for Tampa Bay-area patients.
“When the federal government makes a change like they did, that affects the state of Florida, it is wrong and unacceptable,” Couris said.
TGH has treated over 2,700 patients with monoclonal antibody therapy since the start of COVID-19.
“This change is going to hurt people,” Couris said.
– Staff Report, Extensive Enterprises Media